Clinical Medicine Insights Endocrinology and Diabetes · 2013 · 78 citations · 29 references
MedicineBiochemistryNephrologyDiabetologyRenal PathologyRenal PathophysiologyDiabetic NephropathyRenal AssessmentRenal DiseaseRenal Function TestingRenal Function TestsRenal ImpairmentCystatin CCystatin C-based AssessmentDiabetic Kidney Disease ProgressionNeutrophil Gelatinase-associated LipocalinRenal Dysfunction AssessmentRenal Dysfunction BiomarkersRenal Enzyme MarkersTubulointerstitial Damage Biomarkers
Renal tubulointerstitium plays an important role in the development and progression of diabetic nephropathy. The aim of this study was to assess serum cystatin C and 2 renal tubular enzymes, neutrophil gelatinase associated lipocalin (NGAL) and N-acetyl-beta-D-glucosaminidase (NAG), as screening markers for early renal dysfunction in patients with type 2 diabetes mellitus (T2DM). ROC curve analysis showed that urinary NAG is the most sensitive marker of microalbuminuria and early renal damage with sensitivity of 83.3%, while serum cystatin C was the most sensitive and specific marker of macroalbuminuria and damage progress with sensitivity of 70.8% and specificity of 83.3% versus 70.6% and 83.3% for uNGAL; and 64.7% and 66.7% for NAG, respectively. Our data indicate that urinary NAG is the most sensitive marker for early renal damage in diabetic patients. However, for damage progress, serum cystatin C is the most sensitive and specific marker for follow-up and monitoring renal dysfunction.
29
Practical Clinical Biochemistry
Journal of the American Medical Association · 1955 · 1.5K citations
Pharmacy, Biochemistry, Toxicology +13
American Journal of Kidney Diseases · 2002 · 533 citations
NGAL is an early predictive biomarker of contrast-induced nephropathy in children
Russel Hirsch, Catherine L. Dent, Holly Pfriem et al. · Pediatric Nephrology · 2007 · 457 citations
Medicine, Nephrology, Radiology +12